Botanix Pharmaceuticals
(OTC) BXPHF
Botanix Pharmaceuticals Financials at a Glance
Market Cap
$31.17MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
A$23.98M
Net Income (TTM)
-A$127.98M
EPS (TTM)
-$0.03
P/E Ratio
-0.38
Dividend
$0.00
Beta (Volatility)
0.37 (Low)
Dividend
$0.00
Beta (Volatility)
0.37 (Low)
Price
$0.01
Volume
6,000
Open
$0.01
Price
$0.01
Volume
6,000
Open
$0.01
Previous Close
$0.01
Daily Range
$0.01 - $0.01
52-Week Range
$0.01 - $0.15
Estimated Earnings Date
Aug 28, 2026
Dividend
$0.00
Beta (Volatility)
0.37 (Low)
Price
$0.01
Volume
6,000
Open
$0.01
Previous Close
$0.01
Daily Range
$0.01 - $0.01
52-Week Range
$0.01 - $0.15
Estimated Earnings Date
Aug 28, 2026
BXPHF News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Botanix Pharmaceuticals
Industry
Pharmaceuticals
Sector
Health CareCEO
Howie McKibbon, PharmD
Website
www.botanixpharma.comHeadquarters
West Perth, WA 6005, AU
BXPHF Financials
Key Financial Metrics (TTM)
Gross Margin
-118.23%
Operating Margin
-380.62%
Net Income Margin
-404.72%
Return on Equity
-131.13%
Return on Capital
-76.14%
Return on Assets
-89.99%
Earnings Yield
-2.63%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$31.17MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
2.73B
Volume
6.00K
Avg. Volume
19.19K
Financials (TTM)
Gross Profit
-A$27.72M
Operating Income
-A$123.23M
EBITDA
-A$121.47M
Operating Cash Flow
-A$115.58M
Capital Expenditure
-A$365.23K
Free Cash Flow
-A$115.94M
Cash & ST Invst.
A$31.60M
Total Debt
A$30.04M
Botanix Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
A$16.50M
+4265.7%
Gross Profit
-A$28.75M
-850.5%
Gross Margin
-1.74%
N/A
Market Cap
$31.17MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$2.83M
N/A
Employees
11
N/A
Net Income
-A$33.18M
-506.9%
EBITDA
-A$32.42M
-1075.1%
Quarterly Fundamentals
Total Cash
A$31.60M
+72.6%
Total Debt
A$30.04M
N/A
Accounts Receivable
A$5.70M
+2496.0%
Inventory
A$27.50M
+778.0%
Long Term Debt
A$16.91M
N/A
Short Term Debt
A$13.13M
N/A
Return on Assets
-89.99%
N/A
Return on Invested Capital
-1.18%
N/A
Free Cash Flow
-A$32.63M
-76.0%
Operating Cash Flow
-A$32.63M
-767.7%